{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:09:27Z","timestamp":1793189367260,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"DFID\/NIHR\/MRC\/Wellcome Trust Global Health Trials Scheme"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The World Health Organization (WHO) recommends consideration of mass drug administration (MDA) for malaria control in low-endemic settings approaching elimination. However, MDA remains a controversial strategy, as multiple individual, social, and operational factors have shown to affect its acceptability at local levels. This is further complicated by inconsistent definitions of key indicators derived from individual and community involvement\u2014coverage, adherence, and compliance\u2014that cast doubts about the actual and potential epidemiological impact of MDA on disease control and elimination. This study aimed to identify limitations and enabling factors impacting involvement at different stages of a large cluster-randomized trial assessing the effect of combining dihydroartemisinin-piperaquine (DP) and ivermectin (IVM) in malaria transmission in The Gambia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This social science study used a mixed-methods approach. Qualitative data were collected in intervention and control villages through ethnographic methods, including in-depth interviews (IDIs), focus group discussions (FGDs), and participant observation conducted with trial participants and decliners, community leaders, and field staff. A cross-sectional survey was conducted in the intervention villages after the first year of MDA. Both strands of the study explored malaria knowledge and opinions, social dynamics influencing decision-making, as well as perceived risks, burdens, and benefits associated with this MDA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>157 IDIs and 11 FGDs were conducted, and 864 respondents were included in the survey. Barriers and enabling factors to involvement were differentially influential at the various stages of the MDA. Issues of social influence, concerns regarding secondary effects of the medication, costs associated with malaria, and acceptability of the implementing organization, among other factors, differently affected the decision-making processes throughout the trial. Rather than a linear trajectory, involvement in this MDA trial was subjected to multiple revaluations from enrolment and consent to medicine intake and adherence to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study went beyond the individual factors often associated with coverage and adherence, and found that nuanced social dynamics greatly influence the decision-making process at all phases of the trial. These issues need to be consider for MDA implementation strategies and inform discussions about more accurate ways of reporting on critical effectiveness indicators.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-021-03732-z","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T07:03:11Z","timestamp":1619420591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-8044","authenticated-orcid":false,"given":"Alexandra","family":"Fehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Nieto-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Muela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatou","family":"Jaiteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ceesay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrima","family":"Maneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dullo","family":"Baldeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Achan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgard","family":"Dabira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakary","family":"Conteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joske","family":"Bunders-Aelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Smekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Broekhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Peeters Grietens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"3732_CR1","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1098\/rstb.2013.0434","volume":"369","author":"JP Webster","year":"2014","unstructured":"Webster JP, Molyneux DH, Hotez PJ, Fenwick A. The contribution of mass drug administration to global health: past, present and future. Philos Trans R Soc B Biol Sci. 2014;369:1645.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"3732_CR2","unstructured":"WHO. The role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria. Malaria Policy Advisory Committee Meeting. 2015."},{"key":"3732_CR3","first-page":"CD008846","volume":"12","author":"E Poirot","year":"2013","unstructured":"Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;12:CD008846.","journal-title":"Cochrane Database Syst Rev."},{"key":"3732_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/inthealth\/ihy079","volume":"11","author":"N Kaehler","year":"2019","unstructured":"Kaehler N, Adhikari B, Cheah PY, Day NPJ, Paris DH, Tanner M, et al. The promise, problems and pitfalls of mass drug administration for malaria elimination: a qualitative study with scientists and policymakers. Int Health. 2019;11:166\u201376.","journal-title":"Int Health"},{"issue":"93","key":"3732_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"8","author":"G Newby","year":"2015","unstructured":"Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of Mass Drug Administration for Malaria and Its Operational Challenges. Am J Trop Med Hyg. 2015;8(93):125\u201334.","journal-title":"Am J Trop Med Hyg"},{"key":"3732_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12936-015-0931-9","volume":"14","author":"M Whittaker","year":"2015","unstructured":"Whittaker M, Smith C. Reimagining malaria: five reasons to strengthen community engagement in the lead up to malaria elimination. Malar J. 2015;14:410.","journal-title":"Malar J"},{"key":"3732_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12936-016-1593-y","volume":"15","author":"B Adhikari","year":"2016","unstructured":"Adhikari B, James N, Newby G, von Seidlein L, White NJ, Day NPJ, et al. Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review. Malar J. 2016;15:523.","journal-title":"Malar J"},{"key":"3732_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/dewb.12160","volume":"18","author":"S Dierickx","year":"2018","unstructured":"Dierickx S, O\u2019Neill S, Gryseels C, Immaculate Anyango E, Bannister-Tyrrell M, Okebe J, et al. Community sensitization and decision-making for trial participation: a mixed-methods study from The Gambia. Dev World Bioeth. 2018;18:406\u201319.","journal-title":"Dev World Bioeth"},{"key":"3732_CR9","doi-asserted-by":"publisher","first-page":"e0148627","DOI":"10.1371\/journal.pone.0148627","volume":"11","author":"S Dierickx","year":"2016","unstructured":"Dierickx S, Gryseels C, Mwesigwa J, O\u2019Neill S, Bannister-Tyrell M, Ronse M, et al. Factors associated with non-participation and non-adherence in directly observed mass drug administration for malaria in The Gambia. PLoS ONE. 2016;11:e0148627.","journal-title":"PLoS ONE"},{"key":"3732_CR10","doi-asserted-by":"publisher","first-page":"e0214280","DOI":"10.1371\/journal.pone.0214280","volume":"14","author":"CL Pell","year":"2019","unstructured":"Pell CL, Adhikari B, Myo Thwin M, Kajeechiwa L, Nosten S, Nosten FH, et al. Community engagement, social context and coverage of mass anti-malarial administration: comparative findings from multi-site research in the Greater Mekong sub-Region. PLoS ONE. 2019;14:e0214280.","journal-title":"PLoS ONE"},{"key":"3732_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12936-019-2672-7","volume":"18","author":"F Jaiteh","year":"2019","unstructured":"Jaiteh F, Masunaga Y, Okebe J, D\u2019Alessandro U, Balen J, Bradley J, et al. Community perspectives on treating asymptomatic infections for malaria elimination in the Gambia. Malar J. 2019;18:39.","journal-title":"Malar J"},{"key":"3732_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1475-2875-13-47","volume":"13","author":"NJ Dial","year":"2014","unstructured":"Dial NJ, Ceesay SJ, Gosling RD, D\u2019Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in the Gambia. Malar J. 2014;13:47.","journal-title":"Malar J"},{"key":"3732_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1478-4505-9-3","volume":"9","author":"M Parker","year":"2011","unstructured":"Parker M, Allen T. Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda. Heal Res Policy Syst. 2011;9:3.","journal-title":"Heal Res Policy Syst"},{"key":"3732_CR14","unstructured":"WHO. Mass drug administration for falciparum malaria: a practical field manual. The Cochrane database of systematic reviews. Geneva, World Health Organization, 2017."},{"key":"3732_CR15","doi-asserted-by":"publisher","first-page":"e1002745","DOI":"10.1371\/journal.pmed.1002745","volume":"16","author":"L von Seidlein","year":"2019","unstructured":"von Seidlein L, Peto TJ, Landier J, Nguyen T-N, Tripura R, Phommasone K, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: a cluster randomised trial. PLoS Med. 2019;16:e1002745.","journal-title":"PLoS Med"},{"key":"3732_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13063-018-2506-x","volume":"19","author":"J Okebe","year":"2018","unstructured":"Okebe J, Ribera JM, Balen J, Jaiteh F, Masunaga Y, Nwakanma D, et al. Reactive community-based self-administered treatment against residual malaria transmission: Study protocol for a randomized controlled trial. Trials. 2018;19:126.","journal-title":"Trials"},{"key":"3732_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13071-018-2944-z","volume":"11","author":"G-R Kamga","year":"2018","unstructured":"Kamga G-R, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Ghogomu SM, Souopgui J, et al. Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon. Parasit Vectors. 2018;11:356.","journal-title":"Parasit Vectors"},{"key":"3732_CR18","doi-asserted-by":"publisher","first-page":"e24871","DOI":"10.1371\/journal.pone.0024871","volume":"6","author":"E Patouillard","year":"2011","unstructured":"Patouillard E, Conteh L, Webster J, Kweku M, Chandramohan D, Greenwood B. Coverage, adherence and costs of intermittent preventive treatment of malaria in children employing different delivery strategies in Jasikan. Ghana PLoS One. 2011;6:e24871.","journal-title":"Ghana PLoS One"},{"key":"3732_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12936-018-2541-9","volume":"17","author":"T Pongvongsa","year":"2018","unstructured":"Pongvongsa T, Phommasone K, Adhikari B, Henriques G, Chotivanich K, Hanboonkunupakarn B, et al. The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin\u2013piperaquine plus a single low dose of primaquine in Savannakhet Province. Laos Malar J. 2018;17:405.","journal-title":"Laos Malar J"},{"key":"3732_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.socscimed.2016.08.019","volume":"166","author":"P Kingori","year":"2016","unstructured":"Kingori P, Gerrets R. Morals, morale and motivations in data fabrication: medical research fieldworkers views and practices in two Sub-Saharan African contexts. Soc Sci Med. 2016;166:150\u20139.","journal-title":"Soc Sci Med"},{"key":"3732_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/09581596.2019.1597965","volume":"29","author":"K Peeters Grietens","year":"2019","unstructured":"Peeters Grietens K, Gryseels C, Verschraegen G. Misdirection in the margins of malaria elimination methods. Crit Public Health. 2019;29:390\u2013400.","journal-title":"Crit Public Health"},{"key":"3732_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/inthealth\/ihw027","volume":"8","author":"PY Cheah","year":"2016","unstructured":"Cheah PY, White NJ. Antimalarial mass drug administration: ethical considerations. Int Health. 2016;8:235\u20138.","journal-title":"Int Health"},{"key":"3732_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/cid\/ciu802","volume":"60","author":"RW Steketee","year":"2015","unstructured":"Steketee RW, ter Kuile FO. Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission? Clin Infect Dis. 2015;60:366\u20138.","journal-title":"Clin Infect Dis"},{"key":"3732_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pt.2011.05.007","volume":"27","author":"BD Foy","year":"2011","unstructured":"Foy BD, Kobylinski KC, da Silva IM, Rasgon JL, Sylla M. Endectocides for malaria control. Trends Parasitol. 2011;27:423\u20138.","journal-title":"Trends Parasitol"},{"key":"3732_CR25","first-page":"184","volume":"10","author":"MR Reddy","year":"2011","unstructured":"Reddy MR, Overgaard HJ, Abaga S, Reddy VP, Caccone A, Kiszewski AE, et al. Outdoor host seeking behaviour of Anopheles gambiae mosquitoes following initiation of malaria vector control on Bioko Island. Equatorial Guinea Malar J. 2011;10:184.","journal-title":"Equatorial Guinea Malar J"},{"key":"3732_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14787210.2017.1271713","volume":"15","author":"H Alout","year":"2017","unstructured":"Alout H, Foy BD. Ivermectin: a complimentary weapon against the spread of malaria? Expert Rev Anti Infect Ther. 2017;15:231\u201340.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3732_CR27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12864-015-2029-8","volume":"16","author":"JA Seaman","year":"2015","unstructured":"Seaman JA, Alout H, Meyers JI, Stenglein MD, Dabir\u00e9 RK, Lozano-Fuentes S, et al. Age and prior blood feeding of Anopheles gambiae influences their susceptibility and gene expression patterns to ivermectin-containing blood meals. BMC Genomics. 2015;16:797.","journal-title":"BMC Genomics"},{"key":"3732_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(19)30633-4","volume":"20","author":"HC Slater","year":"2020","unstructured":"Slater HC, Foy BD, Kobylinski K, Chaccour C, Watson OJ, Hellewell J, et al. Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study. Lancet Infect Dis. 2020;20:498\u2013508.","journal-title":"Lancet Infect Dis"},{"key":"3732_CR29","doi-asserted-by":"publisher","first-page":"e0187059","DOI":"10.1371\/journal.pone.0187059","volume":"12","author":"J Mwesigwa","year":"2017","unstructured":"Mwesigwa J, Achan J, Di Tanna GL, Affara M, Jawara M, Worwui A, et al. Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions. PLoS ONE. 2017;12:e0187059.","journal-title":"PLoS ONE"},{"key":"3732_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12936-015-0829-6","volume":"14","author":"J Mwesigwa","year":"2015","unstructured":"Mwesigwa J, Okebe J, Affara M, Di Tanna GL, Nwakanma D, Janha O, et al. On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey. Malar J. 2015;14:314.","journal-title":"Malar J"},{"key":"3732_CR31","first-page":"197","volume":"93","author":"S Dierickx","year":"2015","unstructured":"Dierickx S, Gryseels C, Mwesigwa J, O\u2019Neill S, Jaiteh F, Bannister-Tyrrell M, et al. Community barriers for the implementation of a mass drugs administration for malaria in the Gambia. Am J Trop Med Hyg. 2015;93:197.","journal-title":"Am J Trop Med Hyg"},{"key":"3732_CR32","doi-asserted-by":"publisher","first-page":"e20904","DOI":"10.2196\/20904","volume":"9","author":"ED Dabira","year":"2020","unstructured":"Dabira ED, Soumare HM, Lindsay SW, Conteh B, Ceesay F, Bradley J, et al. Mass drug administration with high-dose ivermectin and dihydroartemisinin-piperaquine for malaria elimination in an area of low transmission with high coverage of malaria control interventions: Protocol for the massiv cluster randomized clinical trial. JMIR Res Protoc. 2020;9:e20904.","journal-title":"JMIR Res Protoc"},{"key":"3732_CR33","volume-title":"Foundations of mixed methods research : integrating quantitative and qualitative approaches in the social and behavioral sciences","author":"C Teddie","year":"2009","unstructured":"Teddie C, Tashakkori A. Foundations of mixed methods research\u202f: integrating quantitative and qualitative approaches in the social and behavioral sciences. Thousand Oaks: Sage Publications; 2009."},{"key":"3732_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12936-017-2158-4","volume":"17","author":"B Adhikari","year":"2018","unstructured":"Adhikari B, Phommasone K, Kommarasy P, Soundala X, Souvanthong P, Pongvongsa T, et al. Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos). Malar J. 2018;17:15.","journal-title":"Malar J"},{"key":"3732_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12936-016-1193-x","volume":"15","author":"R Muela","year":"2016","unstructured":"Muela R, Muela Ribera J, Hausmann-Muela S, Gryseels C, Peeters GK. Re-imagining adherence to treatment from the \u201cother side\u201d: Local interpretations of adverse anti-malarial drug reactions in the Peruvian Amazon. Malar J. 2016;15:136.","journal-title":"Malar J"},{"key":"3732_CR36","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/s41598-021-81468-1","volume":"11","author":"F Jaiteh","year":"2021","unstructured":"Jaiteh F, Okebe J, Masunaga Y, Alessandro UD, Achan J, Gryseels C, et al. Understanding adherence to reactive treatment of asymptomatic malaria infections in The Gambia. Sci Rep. 2021;11:1746.","journal-title":"Sci Rep"},{"key":"3732_CR37","doi-asserted-by":"publisher","first-page":"e2312","DOI":"10.1371\/journal.pntd.0002312","volume":"7","author":"H Rilkoff","year":"2013","unstructured":"Rilkoff H, Tukahebwa EM, Fleming FM, Leslie J, Cole DC. Exploring gender dimensions of treatment programmes for Neglected Tropical Diseases in Uganda. PLoS Negl Trop Dis. 2013;7:e2312.","journal-title":"PLoS Negl Trop Dis"},{"key":"3732_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13012-016-0527-y","volume":"11","author":"V Gopichandran","year":"2016","unstructured":"Gopichandran V, Luyckx VA, Biller-Andorno N, Fairchild A, Singh J, Tran N, et al. Developing the ethics of implementation research in health. Implement Sci. 2016;11:161.","journal-title":"Implement Sci"},{"key":"3732_CR39","doi-asserted-by":"publisher","first-page":"e000320","DOI":"10.1136\/bmjgh-2017-000320","volume":"2","author":"DM Kamuya","year":"2017","unstructured":"Kamuya DM, Molyneux CS, Theobald S. Gendered negotiations for research participation in community-based studies: implications for health research policy and practice. BMJ Glob Health. 2017;2:e000320.","journal-title":"BMJ Glob Health"},{"key":"3732_CR40","first-page":"e80800","volume":"8","author":"L Par\u00e9 Toe","year":"2013","unstructured":"Par\u00e9 Toe L, Ravinetto RM, Dierickx S, Gryseels C, Tinto H, Rouamba N, et al. Could the decision of trial participation precede the informed consent process? Evidence from Burkina Faso PLoS One. 2013;8:e80800.","journal-title":"Evidence from Burkina Faso PLoS One"},{"key":"3732_CR41","first-page":"508","volume-title":"Evidence, Ethos and Experiment: The Anthropology and History of Medical Research in Africa","author":"M Leach","year":"2011","unstructured":"Leach M, Fairhead J. Being, \u201cwith the Medical Research Council\u201d: infant care and social meanings of cohort membership in Gambia\u2019s plural therapeutic landscapes. In: Geissler PW, Molyneux CS, editors. Evidence, Ethos and Experiment: The Anthropology and History of Medical Research in Africa. New York: Berghahn Books; 2011. p. 508."},{"key":"3732_CR42","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.socscimed.2008.02.004","volume":"67","author":"PW Geissler","year":"2008","unstructured":"Geissler PW, Kelly A, Imoukhuede B, Pool R. He is now like a brother, I can even give him some blood\u2019 \u2013 Relational ethics and material exchanges in a malaria vaccine \u2018trial community. The Gambia Soc Sci Med. 2008;67:696\u2013707.","journal-title":"The Gambia Soc Sci Med"},{"key":"3732_CR43","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.socscimed.2006.02.018","volume":"63","author":"J Fairhead","year":"2006","unstructured":"Fairhead J, Leach M, Small M. Where techno-science meets poverty: Medical research and the economy of blood in The Gambia. West Africa Soc Sci Med. 2006;63:1109\u201320.","journal-title":"West Africa Soc Sci Med"},{"key":"3732_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1179\/136485905X29666","volume":"99","author":"P Vanamail","year":"2005","unstructured":"Vanamail P, Ramaiah KD, Subramanian S, Pani SP, Yuvaraj J, Das PK. Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. Ann Trop Med Parasitol. 2005;99:237\u201342.","journal-title":"Ann Trop Med Parasitol"},{"key":"3732_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1475-2875-12-153","volume":"12","author":"CJ Chaccour","year":"2013","unstructured":"Chaccour CJ, Kobylinski KC, Bassat Q, Bousema T, Drakeley C, Alonso P, et al. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J. 2013;12:153.","journal-title":"Malar J"},{"key":"3732_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12936-016-1083-2","volume":"15","author":"U Beisel","year":"2016","unstructured":"Beisel U, Umlauf R, Hutchinson E, Chandler CIR. The complexities of simple technologies: re-imagining the role of rapid diagnostic tests in malaria control efforts. Malar J. 2016;15:64.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03732-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-021-03732-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03732-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T07:10:56Z","timestamp":1619421056000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-021-03732-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3732"],"URL":"https:\/\/doi.org\/10.1186\/s12936-021-03732-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-100622\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"28 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All respondents and their guardians (when under 18\u00a0years old) were explained the purpose of the study by field staff and gave informed consent or assent before being included in the qualitative or quantitative strands. Considering that the act of signing documents is not common practice for local populations and that it could produce mistrust towards the study team, we favored oral over written consent. Both studies were approved by the Institutional Review Board of the Institute of Tropical Medicine, Antwerp, Belgium, by the Scientific Coordinating Committee and the Gambian Government\/MRC Joint Ethics Committee in The Gambia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}